Valtruis

Valtruis is a venture capital firm founded in 2021 and based in New York, New York. The company specializes in investing in and collaborating with innovative leaders within the healthcare sector. Valtruis aims to support disruptive ventures that align with its mission of transforming the healthcare landscape through strategic partnerships and investment.

Anna Haghgooie

Managing Director

Karey Witty

Managing Director

Past deals in Teenagers

InStride Health

Series B in 2024
InStride Health is an outpatient care platform focused on delivering evidence-based treatment for pediatric anxiety and obsessive-compulsive disorder (OCD). The company offers a tailored virtual care journey that includes individual and group therapy, coaching, and medication management, all facilitated by a coordinated team of psychiatrists, therapists, and coaches. This approach ensures that children and teenagers receive effective, accessible, and affordable care, keeping them engaged throughout the treatment process. By prioritizing evidence-based practices, InStride Health aims to enhance the mental well-being of young patients and their families.

InStride Health

Venture Round in 2022
InStride Health is an outpatient care platform focused on delivering evidence-based treatment for pediatric anxiety and obsessive-compulsive disorder (OCD). The company offers a tailored virtual care journey that includes individual and group therapy, coaching, and medication management, all facilitated by a coordinated team of psychiatrists, therapists, and coaches. This approach ensures that children and teenagers receive effective, accessible, and affordable care, keeping them engaged throughout the treatment process. By prioritizing evidence-based practices, InStride Health aims to enhance the mental well-being of young patients and their families.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.